How Much Does Wegovy Cost in 2026?

As of October 8, 2026, Wegovy costs $349 a month without insurance for pens from 0.25 to 2.4 mg, $399 for the 7.2 mg HD pen and $149 to $299 for the pill, on Novo Nordisk’s self-pay offer (Wegovy self-pay prices). New patients pay $199 for their first two pen fills. The list price is $1,349.02 (NovoCare).

How much does Wegovy cost without insurance?

Quick answer: $349 a month for Wegovy pens from 0.25 to 2.4 mg, $399 for the 7.2 mg HD pen and $149–$299 for the pill, as of October 8, 2026.

As checked October 8, 2026, manufacturer offers distinguish tablets from pens. For the 0.25 through 2.4 mg pens, the advertised ongoing price is $349 per box of four pens after any applicable introductory offer; the 7.2 mg HD pen has a separate price. Tablets have dose-specific prices and terms. Confirm the maintenance cost, not only the first fill. Source: Wegovy manufacturer savings terms

Wegovy option	Price	Conditions	Source
Pen 0.25 or 0.5 mg, first two fills	$199	New patients only; per box of 4 pens; through December 31, 2026	Wegovy self-pay prices
Pen 0.25–2.4 mg, self-pay	$349	Per box of 4 pens (28 days)	Wegovy self-pay prices
HD pen 7.2 mg, self-pay	$399	Per box of 4 pens (28 days)	Wegovy self-pay prices
Pill 1.5 / 4 / 9 or 25 mg, self-pay	$149 / $199 / $299	Per bottle of 30 tablets	Wegovy self-pay prices
Costco member price, HD pen 7.2 mg	$399	Costco members, cash; pens and pills matched Novo’s prices at every dose	Costco price search
GoodRx coupon, as low as	$149	The 1.5 mg pill; GoodRx does not show a pharmacy or location	GoodRx
With commercial coverage (savings offer)	$25	Pay as little as; savings capped at $100 per 1-month prescription; no government plans	NovoCare offer terms
List price	$1,349.02	Per package (4 pens or 30 tablets), before discounts and rebates	NovoCare

All figures checked October 8, 2026. Novo Nordisk has announced a $675 monthly list price from January 1, 2027, and says it does not change self-pay prices (Novo Nordisk news release).

How much does Wegovy cost with insurance?

Quick answer: It depends on your plan. With commercial coverage, Novo’s savings offer can bring a fill to as little as $25; government plans cannot use it.

Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. CMS: Medicare GLP-1 Bridge eligibility

Can Medicare lower what I pay for Wegovy?

Quick answer: Possibly. CMS’s Medicare GLP-1 Bridge sets a $50 copay for eligible Part D members, July 1, 2026, to December 31, 2027, for certain GLP-1 drugs.

The Bridge is a short-term CMS demonstration that runs outside the normal Part D benefit. CMS’s page does not list the drugs it covers, so ask your Part D plan whether Wegovy is included and whether you qualify. CMS: Medicare GLP-1 Bridge

What do REMEVi plans cost, and how are they billed?

Quick answer: REMEVi bills every four weeks, not by calendar month, and the 12- and 24-week plans are paid upfront. These are compounded preparations, not Wegovy.

REMEVi prices use four-week billing periods, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included.

Compounded preparation	Every 4 weeks	12 weeks: total upfront	24 weeks: total upfront
Injectable semaglutide	$199	$507 ($169/4 weeks)	$954 ($159/4 weeks)
Injectable tirzepatide	$269	$699 ($233/4 weeks)	$1,350 ($225/4 weeks)
Compounded oral semaglutide	$249	$687 ($229/4 weeks)	$1,290 ($215/4 weeks)

See current semaglutide and tirzepatide plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana.

Is compounded semaglutide FDA-approved?

Quick answer: No. Compounded preparations are not FDA-approved, are not generics of Wegovy or any brand, and have no established clinical equivalence to them.

Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. Source: FDA: unapproved GLP-1 medicines

What should I check before choosing?

Quick answer: The product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy — and who handles side effects.

Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. Review care options.